Duquesnoy R J, Trager J D, Zeevi A
Technological University of Delft, The Netherlands.
Crit Rev Immunol. 1991;10(6):455-80.
This review shows that the propagation and characterization of lymphocytes from various solid organ allografts leads to a better understanding of cellular transplant immunity. Clinically relevant information generated by many studies offers opportunities for better management of transplant patients for cellular rejection. These studies provide experimental support of the importance of various class I and class II HLA antigens in cellular rejection, and frequently the population of infiltrating alloreactive T cells is clonally restricted. Evidence has also accumulated that class I-specific CD8+ cells often appear first in the allograft undergoing early rejection. Allograft derived lymphocytes can also be used in in vitro models to study interactions with vascular endothelium and other targets of cellular rejection. Studies on biopsy propagated cells have also increased our understanding of chronic rejection and intragraft tolerance. Nevertheless, many unanswered questions remain which need to be addressed in future studies. This particularly applies to the mechanism of intragraft T-cell clonality and the characterization of cells mediating chronic rejection or transplant tolerance. A major area of investigation needed over the next few years should address the role of cytokines in the complex interactions between cells mediating the inflammatory process during allograft rejection and the mechanisms of donor tissue injury. This can be done by determining cytokine release by allograft derived cell cultures and by applying molecular techniques to measure in situ production of cytokines in allograft tissue specimens. Given the plethora of cytokines identified so far (the list is still growing), it would be difficult to determine the functional role of individual cytokines in the inflammatory process. Most cytokines have been ascribed multiple functions and for several, their activity requires a synergism with other cytokines or immune modulators. The biological significance of cytokine function must be assessed at different phases during the cascade of effector mechanisms leading to cellular rejection. The first phase pertains to the interactions between lymphocytes and the vascular endothelium. Major events include lymphocyte adhesion to the EC, specific allorecognition, and cellular activation. A variety of cytokines have been identified which upregulate the expression of adhesion molecules and HLA alloantigens at the cell surface. This augments the activated state of the adhering T cells and also triggers the endothelium to attract other leukocytes and permit diapedesis of adhering cells. Although at least four systems of interrelated adhesion receptor-ligand combinations have been shown to influence lymphocyte-endothelium interactions, it is unclear how much each contributes to the process of lymphocyte infiltration through the vascular endothelial barrier.(ABSTRACT TRUNCATED AT 400 WORDS)
本综述表明,对来自各种实体器官同种异体移植物的淋巴细胞进行增殖和特性分析,有助于更好地理解细胞移植免疫。许多研究产生的临床相关信息为更好地管理移植患者的细胞排斥反应提供了机会。这些研究为各类I类和II类HLA抗原在细胞排斥反应中的重要性提供了实验支持,并且浸润的同种异体反应性T细胞群体通常受到克隆限制。也有越来越多的证据表明,I类特异性CD8 +细胞通常在发生早期排斥反应的同种异体移植物中首先出现。同种异体移植物衍生的淋巴细胞也可用于体外模型,以研究其与血管内皮及细胞排斥反应其他靶点的相互作用。对活检增殖细胞的研究也增进了我们对慢性排斥反应和移植物内耐受的理解。然而,仍有许多未解决的问题有待在未来的研究中解决。这尤其适用于移植物内T细胞克隆性的机制以及介导慢性排斥反应或移植耐受的细胞特性。未来几年需要重点研究的一个主要领域应是细胞因子在同种异体移植物排斥反应中介导炎症过程的细胞间复杂相互作用以及供体组织损伤机制中的作用。这可以通过确定同种异体移植物衍生细胞培养物中细胞因子的释放情况以及应用分子技术来测量同种异体移植物组织标本中细胞因子的原位产生来实现。鉴于目前已鉴定出大量细胞因子(且该列表仍在增加),很难确定单个细胞因子在炎症过程中的功能作用。大多数细胞因子具有多种功能,并且对于其中一些细胞因子而言,它们的活性需要与其他细胞因子或免疫调节剂协同作用。细胞因子功能的生物学意义必须在导致细胞排斥反应的效应机制级联反应的不同阶段进行评估。第一阶段涉及淋巴细胞与血管内皮之间的相互作用。主要事件包括淋巴细胞与内皮细胞的粘附、特异性同种异体识别以及细胞活化。已鉴定出多种细胞因子,它们可上调细胞表面粘附分子和HLA同种异体抗原的表达。这增强了粘附T细胞的活化状态,还触发内皮细胞吸引其他白细胞并允许粘附细胞渗出。虽然已显示至少有四个相互关联的粘附受体 - 配体组合系统会影响淋巴细胞 - 内皮细胞相互作用,但尚不清楚每个系统在淋巴细胞通过血管内皮屏障浸润过程中的贡献程度。(摘要截短至400字)